Heigener DF - Search Results

1

Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage.

Heigener DF, Manegold C, Jäger E, Saal JG, Zuna I, Gatzemeier U. Heigener DF, et al. Am J Clin Oncol. 2009 Feb;32(1):61-4. doi: 10.1097/COC.0b013e31817be954. Am J Clin Oncol. 2009. PMID: 19194127 Clinical Trial.

2

[Foreign body aspiration mimicking lung cancer].

Heigener D, Lotz P, Akkan R, Fraedrich J, Welker L, Gatzemeier U. Heigener D, et al. Med Klin (Munich). 2007 Oct 15;102(10):859-60. doi: 10.1007/s00063-007-1106-4. Med Klin (Munich). 2007. PMID: 17928971 German. No abstract available.

3

[Non-small cell lung cancer - diagnostics and stage-adapted therapy].

Heigener DF, Reck M, Gatzemeier U. Heigener DF, et al. Med Klin (Munich). 2007 Dec 15;102(12):981-8; quiz 989-90. doi: 10.1007/s00063-007-1122-4. Med Klin (Munich). 2007. PMID: 18075718 Review. German.

4

[Chemotherapy of malignant pleural mesothelioma: have we made any progress?].

Reck M, Heigener DF, Gatzemeier U. Reck M, et al. Among authors: heigener df. Zentralbl Chir. 2008 Jun;133(3):238-42. doi: 10.1055/s-2008-1004809. Zentralbl Chir. 2008. PMID: 18563688 Review. German.

5

Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphoma.

Engert A, del Giglio A, Bias P, Lubenau H, Gatzemeier U, Heigener D. Engert A, et al. Onkologie. 2009 Oct;32(10):599-604. doi: 10.1159/000232580. Epub 2009 Sep 14. Onkologie. 2009. PMID: 19816079

6

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study.

Reck M, Frickhofen N, Cedres S, Gatzemeier U, Heigener D, Fuhr HG, Thall A, Lanzalone S, Stephenson P, Ruiz-Garcia A, Chao R, Felip E. Reck M, et al. Lung Cancer. 2010 Nov;70(2):180-7. doi: 10.1016/j.lungcan.2010.01.016. Epub 2010 Feb 25. Lung Cancer. 2010. PMID: 20188433 Clinical Trial.

7

Diagnostics and staging procedures in non-small cell lung cancer - is less more?

Heigener DF, Diemel KD, Reck M, Gatzemeier U. Heigener DF, et al. Clin Respir J. 2008 Apr;2(2):67-73. doi: 10.1111/j.1752-699X.2008.00049.x. Clin Respir J. 2008. PMID: 20298309 Review.

8

Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study.

Reck M, van Zandwijk N, Gridelli C, Baliko Z, Rischin D, Allan S, Krzakowski M, Heigener D. Reck M, et al. J Thorac Oncol. 2010 Oct;5(10):1616-22. doi: 10.1097/JTO.0b013e3181f1c7b0. J Thorac Oncol. 2010. PMID: 20736854 Free article. Clinical Trial.

9

Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study.

Heigener DF, Wu YL, van Zandwijk N, Mali P, Horwood K, Reck M. Heigener DF, et al. Lung Cancer. 2011 Nov;74(2):274-9. doi: 10.1016/j.lungcan.2011.02.017. Epub 2011 Mar 24. Lung Cancer. 2011. PMID: 21439671 Clinical Trial.

10

Non-small cell lung cancer in never-smokers: a new disease entity?

Heigener DF. Heigener DF. Onkologie. 2011;34(4):202-7. doi: 10.1159/000326839. Epub 2011 Mar 18. Onkologie. 2011. PMID: 21447981 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters